Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria signs supply agreement with Israeli medical cannabis producer

Stockhouse Editorial
1 Comment| August 5, 2020

{{labelSign}}  Favorites
{{errorMessage}}

Click to enlargeCanadian cannabis licensed producer Aphria Inc. (APHA) (TSX.APHA) has inked a new deal to provide Israeli medical-cannabis company Canndoc with dried bulk flower for a period that could last as long as seven years.

During the first two-year term, Leamington, Ont.-based Aphria will send 3,000 kilograms of dried flower to Canndoc to be incorporated into finished medical-grade cannabis to be co-branded by both companies.

The deal includes mutual options for a pair of two-year extensions, as well as an additional one-year option.

New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.


{{labelSign}}  Favorites
{{errorMessage}}

Comments

No comments yet. Be first to comment!

Leave a Comment

You must be logged in to be able to post a comment.

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today